Clinical trial
ALFAURUS: A DB Randomized Parallel Group Study of Alfuzosin 10mg OD vs Placebo…
NCT00290030 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00290030 |
|---|---|
| Title | ALFAURUS : A DB Randomized Parallel Group Study of Alfuzosin 10mg OD vs Placebo in the Management of AUR in Patients With a 1st Episode Due to BPH |
| Official title | A Double-Blind Randomized Parallel Group Study of Alfuzosin 10mg OD Versus Placebo in the Management of Acute Urinary Retention in Patients With a First Episode Due to Benign Prostatic Hyperplasia (BPH) |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Prostatic Hyperplasia, Acute Urinary Retention |
| Intervention type | Drug |
| Interventions | Alfuzosin |
| Enrollment | 800 |
| Start date | May 1, 2001 |
| Primary completion | Oct 1, 2004 |
| Completion | Oct 1, 2004 |
| First posted | Feb 10, 2006 |
| Last update posted | Mar 12, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: